Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2024-05-08 AGM Information
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Notice of Biohit Oyj's Annual General Meeting
AGM Information Classification · 100% confidence The document is explicitly titled 'Biohit Oyj:n yhtiökokouskutsu' (Biohit Oyj's Notice of General Meeting) and details the agenda for a meeting scheduled for June 5, 2024. The agenda includes standard items for an Annual General Meeting (AGM), such as presenting the 2023 financial statements, deciding on profit distribution (dividend), electing board members, and approving auditor fees. This content directly corresponds to the purpose of an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2024-05-08 Finnish
Notice of Biohit Oyj's Annual General Meeting
AGM Information Classification · 100% confidence The document is explicitly titled "Notice of Biohit Oyj's Annual General Meeting" and details the agenda, date (June 5, 2024), location, and procedures for shareholder participation. The agenda items cover the presentation of the 2023 Financial Statements, dividend proposals, election of the Board, and remuneration reports, which are standard components of an AGM notice. This directly corresponds to the definition of AGM Information.
2024-05-08 English
Biohit Plc B-shares Subscribed with Stock Options I 2021B and I 2022B
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a press release from Biohit Oyj dated March 27, 2024, announcing the subscription of new B-shares using specific option rights (I 2021B and I 2022B). It details the number of shares issued (60,000), the subscription price (€1.00), the resulting total number of shares (15,173,593), and the registration date. This announcement directly concerns a change in the company's capital structure due to the exercise of employee/shareholder options, which fits the definition of 'Capital/Financing Update' (CAP). It is not a general earnings release (ER), a full annual report (10-K), or a simple notice of dividend (DIV). Since it is a specific announcement about capital structure changes via option exercise, CAP is the most precise fit.
2024-03-27 Finnish
Biohit Plc B-shares Subscribed with Stock Options I 2021B and I 2022B
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Stock Exchange Release' from Biohit Plc dated March 27, 2024. The content explicitly details the subscription of new B-shares using stock options (I 2021B and I 2022B), the resulting increase in the total number of shares, and the effect on the share capital structure. This directly relates to changes in the company's share count and capital structure resulting from option exercises. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not a general announcement of a report (RPA/RNS) because it contains the substantive information itself, nor is it a financing update (CAP) which usually implies raising external debt or equity through a formal offering.
2024-03-27 English
Biohit Oyj - Johdon liiketoimet - Elomaa
Director's Dealing Classification · 100% confidence The document is titled 'Johdon liiketoimet' (Management Transactions) and details a specific share transaction by an executive (Suvi Elomaa) at Biohit Oyj. It includes standard fields for insider trading disclosures such as the person's name, position, instrument type, transaction date, and volume/price. This aligns perfectly with the definition for Director's Dealing (DIRS).
2024-03-20 Finnish
Biohit Plc - Managers' transactions - Elomaa
Director's Dealing Classification · 100% confidence The document is titled 'Managers' transactions' and details a specific share subscription by a senior manager (Suvi Elomaa). It includes standard fields for insider trading notifications such as the person subject to the notification, the issuer, the transaction date, instrument type, and volume/price details. This aligns perfectly with the definition of a Director's Dealing (DIRS) report.
2024-03-20 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.